Scarica l'app Stockscreener
32.47
0.98%
-0.32
Dopo l'orario di chiusura:
32.47
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$32.79
Aprire:
$32.72
Volume 24 ore:
710.28K
Relative Volume:
0.56
Capitalizzazione di mercato:
$1.62B
Reddito:
$239.44M
Utile/perdita netta:
$-80.45M
Rapporto P/E:
-19.92
EPS:
-1.6303
Flusso di cassa netto:
$-40.05M
1 W Prestazione:
+1.25%
1M Prestazione:
+30.93%
6M Prestazione:
+15.96%
1 anno Prestazione:
+72.99%
Intervallo 1D:
$32.47
$33.32
Intervallo di 1 settimana:
$31.16
$33.57
Portata 52W:
$15.59
$35.87
Staar Surgical Co Stock (STAA) Company Profile
Nome
Staar Surgical Co
Settore
Industria
Telefono
(626) 303-7902
Indirizzo
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
32.47 | 1.63B | 239.44M | -80.45M | -40.05M | -1.6303 |
ISRG
Intuitive Surgical Inc
|
438.10 | 155.76B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.63 | 40.30B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.78 | 33.13B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.01 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.05 | 30.31B | 5.54B | 1.52B | 1.74B | 10.37 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2026-02-03 | Iniziato | Wedbush | Neutral |
| 2026-01-16 | Ripresa | Morgan Stanley | Underweight |
| 2025-04-21 | Iniziato | Wells Fargo | Equal Weight |
| 2025-02-12 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-02-12 | Downgrade | Jefferies | Buy → Hold |
| 2025-02-12 | Downgrade | Mizuho | Outperform → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-03-11 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-05 | Downgrade | Needham | Buy → Hold |
| 2023-12-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Iniziato | Piper Sandler | Neutral |
| 2023-02-06 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-12-28 | Reiterato | BTIG Research | Buy |
| 2022-12-08 | Iniziato | Stifel | Hold |
| 2022-11-07 | Aggiornamento | Sidoti | Neutral → Buy |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-04-08 | Iniziato | Needham | Buy |
| 2022-03-28 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-07-09 | Iniziato | Oppenheimer | Perform |
| 2021-01-19 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Downgrade | Sidoti | Buy → Neutral |
| 2020-08-31 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-08-06 | Reiterato | The Benchmark Company | Buy |
| 2020-07-06 | Downgrade | Sidoti | Buy → Neutral |
| 2020-06-24 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-06-15 | Iniziato | Jefferies | Buy |
| 2019-12-04 | Iniziato | BTIG Research | Buy |
| 2018-09-24 | Reiterato | The Benchmark Company | Buy |
| 2018-08-06 | Ripresa | The Benchmark Company | Buy |
| 2017-11-20 | Reiterato | The Benchmark Company | Buy |
| 2017-08-14 | Reiterato | The Benchmark Company | Buy |
| 2017-03-03 | Reiterato | The Benchmark Company | Buy |
| 2016-05-18 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Ripresa | The Benchmark Company | Buy |
| 2013-02-28 | Reiterato | The Benchmark Company | Buy |
| 2012-11-01 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Iniziato | Northland Securities | Outperform |
| 2011-10-25 | Reiterato | The Benchmark Company | Buy |
| 2010-10-12 | Iniziato | Morgan Joseph | Buy |
| 2010-05-11 | Iniziato | Benchmark | Buy |
Mostra tutto
Staar Surgical Co Borsa (STAA) Ultime notizie
What's Driving Broadwood Partners' Deep Dive into STAAR Surgical - Kavout
Midday Stock Roundup: Glaukos Corp. Shares Drop 11% - Orange County Business Journal
5 must-read analyst questions from STAAR Surgical’s Q1 earnings call - MSN
Vision-correction lens maker STAAR hosts May investor talks - Stock Titan
STAAR Surgical Announces Participation in Upcoming Investor Conferences - Yahoo Finance
5 Must-Read Analyst Questions From STAAR Surgical’s Q1 Earnings Call - Yahoo Finance
STAAR Surgical signals standalone strength as Alcon overhang fades after strong Q1 - Investing.com Nigeria
STAAR Surgical (STAA) Q1 2026 Earnings Transcript - AOL.com
STAAR Surgical Q1 2026 Results: Revenue Up 120%, EPS Beats EstimatesNews and Statistics - IndexBox
STAAR Surgical (STAA) interim Co-CEO receives PSUs and share tax withholding - Stock Titan
STAAR Surgical (STAA) interim co-CEO reports PSU vesting and tax withholding - Stock Titan
STAAR Surgical (STAA) CDO logs PSU vesting, tax-withheld shares and new holdings - Stock Titan
STAA Q1 Deep Dive: China Momentum, Cost Discipline, and Stabilized Inventory Drive Turnaround - Yahoo Finance
GABELLI & Co INVESTMENT ADVISERS INC. Sells 40,000 Shares of STAAR Surgical Company $STAA - MarketBeat
Why did STAAR Surgical (STAA) stock jump 20% after hours? - MSN
STAAR Surgical Q1 earnings call highlights - MSN
STAA Stock On Track For Its Fourth Straight Session Of Gains – This Analyst Would Rather Be Early Than Late On Staar’s Growth Story - Stocktwits
STAAR Surgical Co stock (US8577001096): Q1 earnings beat and rating upgrade put focus back on growth - AD HOC NEWS
Is Staar Surgical (STAA) Overvalued After Q1 2026 Earnings Beat? - GuruFocus
STAAR Surgical (NASDAQ:STAA) Upgraded at Wall Street Zen - MarketBeat
STAA Maintained by Wells Fargo -- Price Target Raised to $25.00 - GuruFocus
STAAR targets about 75% gross margin and $225M 2026 spend as Switzerland plans to supply 100% of China lenses - MSN
STAAR Surgical Company (NASDAQ:STAA) Q1 2026 Earnings Call Transcript - Insider Monkey
Staar Surgical Company stock hits 52-week high at 35.7 USD - Investing.com Canada
A Look at Staar Surgical Co (STAA) After 8.9% Gain -- GF Value $29.35 vs Price $32.01 - GuruFocus
STAAR Surgical (STAA) Sees Record Q1 Growth, Analysts Boost Pric - GuruFocus
STAA Maintained by Canaccord Genuity -- Price Target Raised to $32 - GuruFocus
STAA Maintained by Stifel -- Price Target Raised to $31.00 - GuruFocus
STAAR Surgical (STAA) Stock Soars 10% After Impressive Q1 Earnin - GuruFocus
STAA Maintains Rating by Mizuho -- Price Target Raised to $27.00 - GuruFocus
STAA Upgraded by Wedbush -- Price Target Raised to $40 - GuruFocus
STAA stock on track for its fourth straight session of gains – this analyst would rather be early than late on STAAR’s growth story - MSN
STAA Rated Neutral by Piper Sandler -- Price Target Raised to $3 - GuruFocus
Earnings To Watch: STAAR Surgical (STAA) Reports Q1 Results Tomorrow - Yahoo Finance UK
Why is STAAR Surgical stock surging today? By Investing.com - Investing.com Australia
Staar Surgical (STAA) Sees Upgrade to Outperform with Target Pri - GuruFocus
Staar Surgical Posts Upbeat Q1 Results, Joins Cisco, Yeti Holdings And Other Big Stocks Moving Higher On Thursday - Benzinga
Why is STAAR Surgical stock surging today? - Investing.com
Piper Sandler raises STAAR Surgical stock price target on Q1 beat - Investing.com Nigeria
Piper Sandler raises STAAR Surgical stock price target on Q1 beat By Investing.com - Investing.com South Africa
STAAR Surgical (NASDAQ:STAA) Given New $27.00 Price Target at Mizuho - MarketBeat
STAAR Surgical net sales up 119.6% to USD 93.5M in Q1 2026 - Medical Buyer
Staar Surgical Co Azioni (STAA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.79%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):